CLA Generative AI Training Licence

Live

UK collective licensing offer for AI model training, fine-tuning, and RAG over published text content.

Website
cla.co.uk/ai-and-copyright
Latest tracked evidence
Mar 01, 2026PLS launches first opt-in stage for collective AI licensing
Last checked
Jun 24, 2026
Profile updated
May 14, 2026
Primary approach
Licensing collective
Practical force
Contractual licensingCoverage and enforcement depend on participation, represented rights, and the resulting agreements.
Also uses
Formal license
Pipeline
Train / Fine-tune / Retrieve
Status rationale
Publicly available or deployable in the latest catalog review.

Enforcement

Collective contractual licensing. Coordinates licenses and negotiations across participating rights holders.

Coverage and enforcement depend on participation, represented rights, and the resulting agreements.

Catalog status describes public availability, not legal validity, adoption, or proven effectiveness.

What it is

CLA, PLS, and ALCS are extending collective licensing into AI model development, with an opt-in publisher scheme and a content repository for training, fine-tuning, and RAG over published text content.

The offer is a UK collective licensing path focused on explicit permissioning and compliance, rather than crawler preference signals or technical blocking.

CLA Generative AI Training Licence coordinates licensing through a collective for text across the training, fine-tuning, and retrieval stages. It also incorporates formal licensing. Coverage depends on participation, the rights represented, and the agreements reached with users. Public materials describe a currently available initiative; the newest dated source in this profile is “PLS launches first opt-in stage for collective AI licensing” (March 1, 2026). These details describe the published mechanism and evidence, not a finding about legal validity, adoption, or effectiveness.

Limitations

The first opt-in stage is live through PLS, CLA, and ALCS, but key coverage, pricing, buyer uptake, and repertory details still depend on direct engagement with the licensing bodies.

Evidence trail

Adoption signals

No public adoption figure found.